Posts

Posted on

CTS to Present at the 23rd Annual Needham Growth Conference

LISLE, Ill., Jan. 04, 2021 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) will be presenting virtually at the 23rd Annual Needham Growth Conference on January 11, 2021 at 3:30 p.m. (EST). You may access a live webcast of the virtual event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on the CTS Corporation website following the presentation.

About CTS

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, telecommunications/IT, and transportation markets.

For more information, visit www.ctscorp.com.

Contact
Ashish Agrawal
Vice President and Chief Financial Officer

CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA

Telephone: +1 (630) 577-8800
E-mail: [email protected]



Posted on

ENVISION BUILDING PRODUCTS ACQUIRES FAIRWAY ARCHITECTURAL RAILING SOLUTIONS

LAMAR, MISSOURI, Jan. 04, 2021 (GLOBE NEWSWIRE) — Envision Building Products LLC, headquartered in Lamar, Missouri, is pleased to announce its acquisition of Fairway Architectural Railing Solutions.  Fairway is a recognized leader in the railing category and its products are a great complement to Envision’s exceptional composite decking. 

“We believe this is the right partnership to meet the evolving needs of our customers while furthering our ability to create best-in-class outdoor products and achieve our vision in becoming the undisputed market share leader of non-wood railing in the US market. We are excited by Fairway’s opportunities under Envision’s ownership, and we look forward to this dynamic new chapter and the exponential new growth opportunities it brings.” said Greg Burkholder, CEO Fairway Architectural Railing Solutions.

Fairway’s existing management team will remain in place and its current product offering will continue to be offered under the Fairway brand, with Fairway also having the ability to provide its customers access to Envision composite decking.  Envision will likewise be able to offer its customers access to the suite of Fairway railing products.   

“This acquisition expands Envision’s footprint in the outdoor living category and will not only increase market reach but will also provide operational efficiencies,” said Shara Gamble, Vice President of Envision Sales and Marketing.  “The individual strengths of each company are complementary and will have a positive impact on our combined service and product offerings.”

The expanded product offerings provided through the acquisition include comprehensive railing solutions in vinyl, aluminum, steel, composite, and cellular PVC along with unique composite decking products from Envision’s budget friendly Ridge Premium to its luxurious Distinction line of decking.  The addition of Fairway railing solutions is yet another step forward for Envision in the outdoor living category.

“We welcome and look forward to working with Fairway’s employees and customers,” said David Humphreys, Chairman and CEO, Envision Building Products LLC. “Our acquisition of Fairway will build existing relationships, while affording customers the benefits of an expanded product portfolio and capabilities.”

Envision was advised by William Shutzer and Mayer Bick of SB Advisors; Skadden Arps Slate Meagher & Flom; and EY. Stifel served as exclusive financial advisor to Fairway, and Stevens & Lee served as Fairway’s legal counsel.

To learn more about Envision Building Products LLC, visit www.envisiondecking.com.

To learn more about Fairway Architectural Railing Solutions, visit www.fairwayrailing.com.

 

About Envision

Envision Building Products LLC provides homeowners with exceptional decking and railing products to create a beautiful outdoor space. Manufactured in the heartland of the USA, these offerings include Distinction®, Inspiration®, Expression®, Ridge Premium, and EverGrain® composite decking, along with TAM-RAIL® railing.

 

About Fairway

Fairway Architectural Railing Solutions is the leading domestic manufacturer of non-wood technologies including Aluminum, PVC, Cellular PVC, Composite and Steel railing systems for residential and commercial decks, balconies, and terraces. Founded in 1997, Fairway became known for creating smart, architecturally significant, and safe railing systems that can address all application challenges while simplifying the purchasing and installation process experience for dealers, contractors and property owners alike. Headquartered in Mount Joy, Pennsylvania with additional manufacturing facilities in York, Nebraska and Hamilton Township, New Jersey, Fairway offers strategic location capabilities to serve the North American markets.

 

# # #

Attachment 



Kim Eckerman
Envision Building Products LLC
[email protected]

Posted on

Shareholder Alert: Ademi LLP Investigates whether Alaska Communications Systems Group, Inc. has obtained a Fair Price in its transaction with ATN International

PR Newswire

MILWAUKEE, Jan. 4, 2021 /PRNewswire/ — Ademi LLP is investigating Alaska Communications (NASDAQ:ALSK) for possible breaches of fiduciary duty and other violations of the law in its transaction with ATN International.

Click here to learn how to join the action: http://ademilaw.com/case/alaska-communications-systems-group-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi LLP alleges Alaska Communications’ financial outlook is improving and yet Alaska Communications shareholders will receive only $3.40 per share.  The merger agreement unreasonably limits competing bids for Alaska Communications by prohibiting solicitation of further bids, and imposing a termination penalty if Alaska Communications accepts a superior bid. Alaska Communications insiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of Alaska Communications’ board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Alaska Communications.

If you own Alaska Communications common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://ademilaw.com/case/alaska-communications-systems-group-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

 

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-alaska-communications-systems-group-inc-has-obtained-a-fair-price-in-its-transaction-with-atn-international-301200191.html

SOURCE Ademi LLP

Posted on

Executives from CleanSpark, Riot Blockchain, NexTech AR Solutions, MicroStrategy, and Grayscale Investments Share Their Bitcoin Insights

New York, Jan. 04, 2021 (GLOBE NEWSWIRE) — Tech Capital, the trusted source for technology news and analysis, is highlighting recent comments on the rapidly evolving Bitcoin landscape from executives at CleanSpark, Riot Blockchain, NexTech AR Solutions, MicroStrategy, and Grayscale Investments, as the cryptocurrency sets yet another new high.

Bitcoin hit $34,000 on Sunday, having advanced 75% over the month and 360% in the last year.

Two of the hedge fund world’s most successful investors – Stanley Druckenmiller and Paul Tudor Jones – have led fund buying.

Demand is also being driven by corporations pursuing alternative asset allocation strategies, diversification by major institutional holders, the emergence of dedicated funds, and interest generated by retail platforms such as Square and PayPal.

CleanSpark Inc (NASDAQ:CLSK) chairman and CEO see a “substantial opportunity”

CleanSpark Chairman Matthew Schultz and Chief Executive Officer Zachary Bradford say the company is aiming to become the lowest energy cost Bitcoin miner in America following the acquisition of ATL Data Centers.

In the company’s annual shareholder statement, the pair said: “By leveraging our proprietary technologies, the company expects to increase Bitcoin production while lowering total energy costs, thereby maximizing overall profitability.

“The anticipation of producing Bitcoins at what we believe will be potentially the lowest total energy cost in America is expected to be a substantial opportunity to market our proprietary energy solutions to other energy intensive operations throughout the world.”

They added… “Management believes that recent moves by companies such as Square, PayPal, MicroStrategy and others have furthered the validation of Bitcoin, and expects that energy efficiency will soon become a priority. The addition of new miners, paired with the recent market performance of Bitcoin prompted the company to raise our revenue guidance to $30 million for fiscal 2021, 300% of what we successfully delivered in 2020.”

Riot Blockchain Inc (NASDAQ:RIOT) CEO Jeff McGonegal says mining hardware is becoming “increasingly scarce”

Riot Blockchain recently said it expected to increase Bitcoin mining capacity by 65% following $35 million of investment in new equipment.

“Continued growth in deployed miners is paramount to a miner’s success,” said McGonegal. “Expanding the company’s bitcoin mining hash rate and operating on a cost-effective basis is very important, particularly during periods when the Bitcoin spot price has appreciably increased. We are pleased to have secured this latest purchase, especially given that the available supply of mining hardware continues to become increasingly scarce.”

NexTech AR Solutions (OTCQB:NEXCF, CSE:NTAR, FSE:N29) CEO Evan Gappelberg says Bitcoin has the potential to rival gold

The provider of virtual and augmented reality experience technologies and services for e-commerce, education, conferences, and events has doubled its Bitcoin investment to $4 million and may add more in 2021.

“This follow-on investment reflects our strong belief that bitcoin is an excellent long-term store of value and an attractive investment asset with more long-term appreciation potential than holding cash which is currently yielding 0.06%. Bitcoin is a digital version of gold which has a total market capitalization of $10 trillion versus bitcoin’s total market capitalization of just $600 billion,” said Gappelberg.

He continued….“As more institutional capital allocators adapt to this new paradigm we expect that more public companies will elect to diversify their treasury into bitcoin which will push the value of bitcoin closer to the value of gold.”



Watch NexTech AR Solutions CEO Evan Gappelberg’s Livestream Now

MicroStrategy Inc (NASDAQ:MSTR) Chief Financial Officer Phong Le says Bitcoin offers the opportunity for better returns

Last month, business intelligence company MicroStrategy Inc announced that it had purchased an additional 29,646 Bitcoins for US$650mln in cash “in accordance with its treasury reserve policy”. This took its holding to 70,470 coins bought for a reported $1.125 billion. At current prices, the investment is worth almost $2.4 billion.

Phong Le said: “The company continues to believe Bitcoin will provide the opportunity for better returns and preserve the value of our capital over time compared to holding cash. 

“We also remain dedicated to our customers and our goal of operating a growing profitable business intelligence company.”

Grayscale Investments Managing Director Michael Sonnenshein says Bitcoin market needs to “mature and grow”

Grayscale Investments, which manages the Grayscale Bitcoin Investment Trust (OTCMKTS:GBTC), recently lowered the management fee on its other investment vehicle, the Grayscale Digital Large Cap Fund (OTCQX:GDLC), to 2.5%, from 3.0%.

“Grayscale has been the market leader for digital currency investment products since our inception, and we’re focused on bringing our clients products that provide access, transparency, and exposure, all supported by best-in-class service providers,” said Grayscale’s Sonnenshein. “It is extremely important to us that as our industry continues to mature and grow, Grayscale continues to lead in client service and offerings.”

T
ECH CAPITAL

Tech Capital is part of Proactive Investors, which is one of the fastest-growing financial media portals in the world, providing breaking news, commentary, and analysis on listed companies and pre-IPO businesses across the globe.

CONTACT

TECH CAPITAL

+1 604 688 8158

www.tech-capital.com

 



Posted on

Free Flow, Inc. (FFLO) Announces Acquisition Expected to Double the Company’s Revenues and Net Worth

Assets of Inside Auto Parts, Inc. are sold to FFLO – Inside Auto Parts, a new wholly owned Free Flow, Inc. subsidiary

King George, Virginia, Jan. 04, 2021 (GLOBE NEWSWIRE) — Free Flow, Inc. (FFLO:OTCPINK), whose current subsidiaries provide vehicle dismantling and the recycling of OEM auto parts and supplies; scrap metal processing; auto leasing; and investing in additional operating companies, today announced the acquisition of assets of Mineral, Virginia-based Inside Auto Parts, Inc., a salvage dealership and used motor vehicle dealership, an acquisition which is projected to double the Company’s revenues and net worth.

Details of the acquisition will be included in a Current Report on Form 8-K to be filed with the Securities and Exchange Commission in the coming days.

Inside Auto Parts, incorporated in June 1993, is centrally located between Richmond, Charlottesville, and Fredericksburg, Virginia with easy access to main transport routes.  The salvage dealership, specializing in used foreign car and truck parts, represents 90% of the company’s business activity; and the motor vehicle dealership, specializing in used, late model, foreign automobiles, represents 10% of the company’s business activity.

Inside Auto Parts possesses multiple licenses, which cover substantive portions of the auto supply chain and are expected to help further Free Flow’s growth strategies.  The company is licensed to operate as a fully functioning car and motorcycle dealership as well as a licensed salvage dealer, rebuilder, and demolisher able to purchase a vehicle, designate that vehicle salvage, sell parts, and fully demolish remaining components.  The company is also licensed to purchase a salvage vehicle, rebuild, and resell the vehicle and to purchase and sell salvage, rebuildable, and demolished automobiles and parts. All licenses are being transferred to FFLO – Inside Auto Parts, Inc., a wholly owned subsidiary of Free Flow, Inc.

Inside Auto Parts has significant structures to help facilitate Free Flow’s growth strategies, including 21,953.9 square feet fully enclosed and another 17,392.35 square feet under roof enclosed on 3 sides, all located on 16 acres of land in Mineral, Virginia now owned by Free Flow, Inc.

Current management of Inside Auto Parts will remain in place to manage and operate FFLO – Inside Auto Parts.

“This acquisition is tremendously significant due to its immediate impact on the Company’s revenues and net worth,” commented Mr. Sabir Saleem, CEO of Free Flow, Inc.  “Growth through acquisition is a strategy that Free Flow expects to continue to employ.  We believe additional potential acquisition opportunities will present themselves, and these will be evaluated based on their upside potential, their synergies with current operations, their ability to deliver long-term value, and other relevant factors.”   

Any shareholders or interested potential investors who want to receive information directly from Free Flow, Inc. as soon as it has been publicly disclosed, should sign up for the Company’s Email Alert System at https://mailchi.mp/129de3da6ae6/email-alerts.  More information about the Company can be viewed at www.FreeFlowPLC.com. 

To view the Company’s recently completed Offering Memorandum, please visit http://www.freeflowplc.com/offering-memorandum/.

ABOUT
FREE FLOW, INC.

Free Flow, Inc., traded under the stock ticker symbol “FFLO”, is a Delaware company that creates and acquires operating subsidiaries with the goal of manufacturing and selling products and services.  Through its current subsidiaries – Accurate Auto Parts, Inc., Motor & Metals, Inc., and Citi Autos, Corp. – the Company provides OEM (Original Equipment Manufacturer) recycled auto parts and supplies from a warehousing and shipping facility on its 19-plus acre facility in King George, Virginia, and 16 acres in Mineral, VA, USA   Every year, approximately eleven million cars are scrapped and end up in salvage yards for reprocessing.  FFLO helps to reduce the carbon footprint involved in the production of new parts and steel products through the sales of recycled auto parts and supplies.


Safe Harbor Statement: 

This press release may include predictions, estimates, opinions or statements that might be considered “forward-looking” under the provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally can be identified by phrases such as the Company or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” or other, similar words or phrases.



Sabir Saleem 
Free Flow, Inc
703-789-3344

Posted on

ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

PR Newswire

NEW YORK, Jan. 4, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Intercept Pharmaceuticals Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) from September 28, 2019,  through October 7, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Intercept securities, and/or would like to discuss your legal rights and options please visit Intercept Shareholder Lawsuit or contact Joseph R. Seidman Jr.  toll free at (877) 779-1414 or [email protected].

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendants downplayed the true scope and severity of safety concerns associated with Ocaliva’s use in treating PBC; (ii) the foregoing increased the likelihood of an FDA investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA’s efficacy in treating NASH were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company’s NDA for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

On May 22, 2020, Intercept reported that the FDA “has notified Intercept that its tentatively scheduled June 9, 2020 advisory committee meeting (AdCom) relating to the company’s [NDA] for [OCA] for the treatment of liver fibrosis due to [NASH] has been postponed” to “accommodate the review of additional data requested by the FDA that the company intends to submit within the next week.” On this news, Intercept’s stock price fell $11.18 per share, or 12.19%, to close at $80.51 per share on May 22, 2020.

On June 29, 2020, Intercept issued a press release announcing that the FDA had issued a Complete Response Letter (“CRL”) rejecting the Company’s NDA for Ocaliva for the treatment of liver fibrosis due to NASH. According to that press release, “[t]he CRL indicated that, based on the data the FDA has reviewed to date,” the FDA “has determined that the predicted benefit of OCA based on a surrogate histopathologic endpoint remains uncertain and does not sufficiently outweigh the potential risks to support accelerated approval for the treatment of patients with liver fibrosis due to NASH.” The press release further advised, among other things, that the “[t]he FDA recommends that Intercept submit additional post-interim analysis efficacy and safety data from the ongoing REGENERATE study in support of potential accelerated approval and that the long-term outcomes phase of the study should continue.” On this news, Intercept’s stock price fell $30.79 per share, or 39.73%, to close at $46.70 per share on June 29, 2020.

Then, on October 8, 2020, news outlets reported that Intercept was “facing an investigation from the [FDA] over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.” On this news, Intercept’s stock price fell $3.30 per share, or 8.05%, to close at $37.69 per share on October 8, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than January 4, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Intercept securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/interceptpharmaceuticalsinc-icpt-shareholder-class-action-lawsuit-stock-fraud-331/apply/ or contact Joseph R. Seidman Jr.  toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Joseph R. Seidman, Jr.

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/icpt–investor-deadline-alert-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-filed-against-intercept-pharmaceuticals-inc-301199766.html

SOURCE Bernstein Liebhard LLP

Posted on

GT Biopharma (OTCQB: GTBP) Announces Corporate Update Conference Call

Thursday, January 7, 2021 at 4:15 pm ET

PR Newswire

BEVERLY HILLS, Calif., Jan. 4, 2021 /PRNewswire/ — GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s proprietary NK cell engager (TriKE™) technology platform announces that it will be holding a shareholder update call on Thursday, January 7, 2021.

Management will host the conference call on Thursday, January 7, 2021 at 4:15 pm Eastern Time, to review past events and provide an update on its clinical programs and corporate highlights. Following management’s formal remarks, Anthony Cataldo, Chairman and Chief Executive Officer of GT Biopharma will answer submitted questions. Please email your questions prior to the call to [email protected].

Conference Call Information

To join the conference call, live via telephone, interested parties should dial 712-775-7031 approximately 10 minutes before the start of the call. Use confirmation number 576-591-822 followed by the pound sign (#).


About GT Biopharma, Inc.

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE™ NK cell engager platform.  Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient’s immune system natural killer cells (NK cells).  GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology.

For additional information visit www.gtbiopharma.com 


Forward-Looking Statements

This press release contains certain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict, including statements regarding the potential acquisition, the likelihood of closing the potential transaction, our clinical focus, and our current and proposed trials.  Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believes”, “hopes”, “intends”, “estimates”, “expects”, “projects”, “plans”, “anticipates” and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.  Our forward-looking statements are not a guarantee of performance, and actual results could differ materially from those contained in or expressed by such statements.  In evaluating all such statements, we urge you to specifically consider the various risk factors identified in our Form 10-K for the fiscal year ended December 31, 2019 in the section titled “Risk Factors” in Part I, Item 1A and in our subsequent Form 10Q Quarterly filings with the Securities and Exchange Commission, any of which could cause actual results to differ materially from those indicated by our forward-looking statements.

Our forward-looking statements reflect our current views with respect to future events and are based on currently available financial, economic, scientific, and competitive data and information on current business plans.  You should not place undue reliance on our forward-looking statements, which are subject to risks and uncertainties relating to, among other things:  (i) the sufficiency of our cash position and our ongoing ability to raise additional capital to fund our operations, (ii) our ability to complete our contemplated clinical trials, or to meet the FDA’s requirements with respect to safety and efficacy, (iii) our ability to identify patients to enroll in our clinical trials in a timely fashion, (iv) our ability to achieve approval of a marketable product, (v) design, implementation and conduct of clinical trials, (vii) the results of our clinical trials, including the possibility of unfavorable clinical trial results, (vii) the market for, and marketability of, any product that is approved, (viii) the existence or development of treatments that are viewed by medical professionals or patients as superior to our products, (ix) regulatory initiatives, compliance with governmental regulations and the regulatory approval process, and social conditions, and (x) various other matters, many of which are beyond our control.  Should one or more of these risks or uncertainties develop, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those anticipated, believed, estimated, or otherwise indicated by our forward-looking statements.

We intend that all forward-looking statements made in this press release will be subject to the safe harbor protection of the federal securities laws pursuant to Section 27A of the Securities Act, to the extent applicable.  Except as required by law, we do not undertake any responsibility to update these forward-looking statements to take into account events or circumstances that occur after the date of this press release.  Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by these forward-looking statements.

Contact
Andrew Barwicki
516-662-9461 / [email protected] 

Cision View original content:http://www.prnewswire.com/news-releases/gt-biopharma-otcqb-gtbp-announces-corporate-update-conference-call-301200147.html

SOURCE GT Biopharma, Inc.

Posted on

FLIR Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of FLIR Systems, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLIR

FLIR Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of FLIR Systems, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLIR

NEW YORK–(BUSINESS WIRE)–
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of FLIR Systems, Inc. (NASDAQ: FLIR) to Teledyne Technologies Incorporated for $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share is fair to FLIR shareholders.

Halper Sadeh encourages FLIR shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

The investigation concerns whether FLIR and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for FLIR shareholders; (2) determine whether Teledyne is underpaying for FLIR; and (3) disclose all material information necessary for FLIR shareholders to adequately assess and value the merger consideration. On behalf of FLIR shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages FLIR shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

KEYWORDS: Illinois New York United States North America

INDUSTRY KEYWORDS: Other Professional Services Professional Services Legal

MEDIA:

Logo
Logo
Posted on

Teledyne Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Teledyne Technologies Incorporated Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TDY

Teledyne Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Teledyne Technologies Incorporated Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TDY

NEW YORK–(BUSINESS WIRE)–
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Teledyne Technologies Incorporated (NYSE: TDY) and FLIR Systems, Inc. is fair to Teledyne shareholders. Under the terms of the merger agreement, FLIR shareholders will receive $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share.

Halper Sadeh encourages Teledyne shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

The investigation concerns whether Teledyne and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Teledyne shareholders; and (2) disclose all material information necessary for Teledyne shareholders to adequately assess and value the merger consideration. On behalf of Teledyne shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Teledyne shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Mark Twain Saloon and Casino of Virginia City, Nevada Chooses CasinoTrac Management System

PR Newswire

MINNETONKA, Minn., Jan. 4, 2021 /PRNewswire/ — Table Trac, Inc. (OTCQX: TBTC) announced today that it will install its CasinoTrac system and provide services to enhance the player experience at The Mark Twain Saloon and Casino.

The Mark Twain Saloon & Casino has been tucked away along the boardwalk in Virginia City’s Comstock Lode Mining District for more than 47 years. Home to the Gallery of Gunslingers and the “Face on the Barroom Floor“, it’s a great place to stop by for drinks and to try your luck at a game of chance.  Virginia City’s only 24-hour Saloon and Gambling Hall!  The Mark Twain Saloon & Casino was built in 1863 and is one of less than 10 percent of buildings that survived the “Great Conflagration (fire) of 1875″.  In 1971 Dee Schafer bought the building and became the first-or-second woman to receive a non-restricted gaming license in the state of Nevada.  Today the Mark Twain is Virginia City’s preferred stop for gambling. It features an exceptionally convivial staff as a player’s club with many promotions to benefit the gambler.

“Our property is excited to partner with Table Trac, Inc. to continue to improve our operations. We identified a clear need to upgrade our player tracking and accounting capabilities and CasinoTrac was the clear choice,” said Emily Schafer, General Manager of the Mark Twain Saloon and Casino.

Chad Hoehne, President of Table Trac Inc. said, “We are pleased to have The Mark Twain Saloon and Casino joining our growing list of casino system customers.  We care about making our system easy to use and easy to own, with a commitment to service and value.”

About Table Trac, Inc.

Founded in 1995, Table Trac, Inc. designs, develops and sells casino management systems. CasinoTrac is currently operating in casinos across 13 countries including the United States, Central and South America, the Caribbean, and Australia. More information is available at http://www.tabletrac.com/.

Forward Looking Statements

This press release contains forward-looking statements that involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in the Company’s filings with the Securities and Exchange Commission.

For more information:

Robert Siqveland

Table Trac, Inc.
952-548-8877

 

Cision View original content:http://www.prnewswire.com/news-releases/mark-twain-saloon-and-casino-of-virginia-city-nevada-chooses-casinotrac-management-system-301200262.html

SOURCE Table Trac, Inc.